GlassScriptPhysician profile
Brett W Cox
NPI 1811192099
$2,618.25
in general payments reported to CMS, 2019-2025
17 companies · $534 in 2025
The $534 reported for 2025 was more than what 76% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $9.40 · 2022: $576 · 2023: $225 · 2024: $575 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragenics Corporation | $699.42 | 2019 | |
| Bioprotect Medical, INC. | $546.25 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $286.68 | 2022 | |
| Janssen Biotech, INC. | $168.63 | 2025 | Erleada |
| Astrazeneca Uk Limited | $157.75 | 2024 | |
| Accord Healthcare, INC. | $150.79 | 2024 | |
| Dendreon Pharmaceuticals LLC | $138.88 | 2023 | Provenge |
| Astrazeneca Pharmaceuticals LP | $117.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.65 | 2022-2025 | |
| Axonics, INC. | $66.01 | 2022 | |
| Palette Life Sciences, INC. | $47.42 | 2023 | |
| Blue Earth Diagnostics | $35.07 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $34.43 | 2022 | |
| Novartis Pharmaceuticals Corporation | $29.89 | 2024 | |
| Sumitomo Pharma America, INC. | $27.48 | 2025 | Orgovyx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $24.43 | 2022 | |
| Vapotherm INC | $9.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.